Cancer Gene Therapy
Reports Summarize Cancer Gene Therapy Study Results from Tarbiat Modares University
Published in Gene Therapy Weekly, January 19th, 2012
2012 JAN 19 -- New investigation results, "Combined MUC1-specific nanobody-tagged PEG-polyethylenimine polyplex targeting and transcriptional targeting of tBid transgene for directed killing of MUC1 over-expressing tumour cells," are detailed in a study published in Journal of Controlled Release. "We provide evidence for combining a single domain antibody (nanobody)-based targeting approach with transcriptional targeting as a safe way to deliver lethal transgenes to MUC1 over-expressing cancer cells. From a nanobody immune library, we have isolated an anti-DF3/Mucin1 (MUC1) nanobody with high specificity for the MUC1 antigen, which is an aberrantly glycosylated...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Gene Therapy Weekly
Source: Gene Therapy Weekly (2012-01-19)
More Articles from Gene Therapy Weekly
- Enzymes and Coenzymes
Study Findings from NanJing University Provide New Insights into Enzymes and Coenzymes - Diabetes
Study Findings on Diabetes Are Outlined in Reports from Inje University - Xenografts
Study Data from X. Zeng et al Provide New Insights into Xenografts - Hepatocellular Cancer
Study Data from University Hospital Provide New Insights into Hepatocellular Cancer - Gene Therapy
Studies from University of Minnesota Describe New Findings in Gene Therapy - Cancer Gene Therapy
Studies from University of Texas Southwestern Reveal New Findings on Cancer Gene Therapy - More from this issue of Gene Therapy Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
